News Conference News STS 2020 For Congenital Heart Disease, SAVR With Bioprosthetic Valve Still Reigns Yael L. Maxwell January 30, 2020
News Conference News STS 2020 TAVR Tussle at US Surgery Meeting Threatens to Widen Surgeon-Cardiologist Wedge Yael L. Maxwell January 29, 2020
News Conference News LINC 2020 COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose L.A. McKeown January 28, 2020
News Conference News ISET 2020 Leaving the Hospital Nest? OBL Advice From Those Who’ve Done It Caitlin E. Cox January 28, 2020
News Daily News FFR for Stable Patients With Intermediate CAD? VA Analysis Stokes Debate Michael O'Riordan January 27, 2020
News Conference News ISET 2020 FDA’s First Take on New Paclitaxel Concerns in CLI Caitlin E. Cox January 24, 2020
News Daily News MitraClip in the US: As Coverage Update Looms, Some Questions for REPAIR MR Shelley Wood January 24, 2020
News Daily News ‘Super-Dense’ Calcified Plaque Appears Protective Against ACS Michael O'Riordan January 24, 2020
News Daily News Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL Michael O'Riordan January 17, 2020
News Daily News Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI L.A. McKeown January 15, 2020
News Daily News For Some, Routine Cardiac Monitoring May Be Unnecessary After PCI L.A. McKeown January 13, 2020
News Daily News Obesity and Aortic Stenosis: Genetic Analysis Hints at Causal Link Yael L. Maxwell January 13, 2020
News Daily News Diabetes Does Not Appear to Hinder FFR Insights for CAD Caitlin E. Cox January 09, 2020
News Daily News FFR Can Safely Guide PCI Deferral, With Solid Long-term Results: J-CONFIRM Caitlin E. Cox January 03, 2020
News Opinion Conversations in Cardiology Conversations in Cardiology: In the ISCHEMIA Era, What Role for FFR? January 02, 2020
News Daily News NOBLE at 5 Years: New Data Favor CABG for Left Main Disease Todd Neale December 23, 2019
News Daily News CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization Michael O'Riordan December 20, 2019
News Features Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too Michael O'Riordan December 18, 2019